India equity benchmarks to open flat; pharma in focus after US tariffs on branded drugs
India's equity benchmarks are likely to open little changed on Friday, but the sentiment will be one of caution as tariff worries resurfaced after U.S. President Donald Trump announced a 100% levy on branded drugs and 25% on heavy-duty trucks.

What's Your Reaction?











